Vitíligo asociado a inhibidores de cinasas dependientes de las ciclinas 4 y 6
José María Camino Salvador
[1]
;
Consuelo Sánchez Herreros
[1]
;
María de la Paloma Arribas Granados
[2]
;
Esther de Eusebio Murillo
[3]
[1]
Hospital Universitario de Guadalajara
Hospital Universitario de Guadalajara
Guadalajara,España
[2]
Servicio de Anatomía Patológica, Hospital Universitario de Guadalajara, Guadalajara, España. Departamento de Medicina y Especialidades Médicas, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Alcalá de Henares, España
[3]
Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, España. Departamento de Medicina y Especialidades Médicas, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Alcalá de Henares, España
Naranjo CA, Busto U, Sellers EM, et al. Roberts E.A.,et al. A
method for estimating the probability of adverse drug
reactions. Clin Pharmacol...
Garutti M, Targato G, Buriolla S, et al. CDK4/6 inhibitors in
melanoma: a comprehensive review. Cells. 2021;10(6):1334.
https://doi.org/10.3390/cells10061334.
Raschi E, Fusaroli M, La Placa M, et al. Skin toxicities with
cyclin-dependent kinase 4/6 inhibitors in breast cancer:
signals from disproportionality...
Vrana E, Mylona S, Bobos M, et al. Ribociclib and palbociclibinduced erythema multiforme: a case report. Oxf Med Case Rep.
2022;2022(11)....
Silvestri M, Cristaudo A, Morrone A, et al. Emerging skin
toxicities in patients with breast cancer treated with new
cyclin-dependent kinase...
Salusti-Simpson M, Porter H, Morley K. A likely case of
abemaciclib-induced hyperpigmentation in a patient with
metastatic breast cancer....
Alikhan A, Felsten LM, Daly M, et al. Vitiligo: a comprehensive
overview Part I. Introduction, epidemiology, quality of life,
diagnosis, differential...
Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview part II: treatment options and approach to
treatment. J Am Acad...
Teulings HE, Limpens J, Jansen SN, et al. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving
immunotherapy and...
Sollena P, Nikolaou V, Soupos N. et al. Vitiligo-like lesions in
patients with advanced breast cancer treated with cyclinedependent kinases...
Silvestre Torner N, Aguilar Martínez A, Echarri González MJ,
et al.Ribociclib-induced vitiligo: a case report Dermatol Pract
Concept. 2022;12(2):e2022045....
Anjaneyan G, Keechilat P, Duraisamy P, et al.Ribociclibinduced extensive vitiligo-like lesions: possible
pathomechanisms with clinical, dermoscopic...
Chan OB, Su JC, Yazdabadi A, et al. Drug induced vitiligo-like
depigmentation from a CDK 4/6 inhibitor. Asia Pac J Clin Oncol.
2022;18(2):e154–e156....
Sharaf B, AlMasri R, Abdel-Razeq N, Salama O, Hamad I.
Abunasser M.,et al. Vitiligo-like lesions in a patient with
metastatic breast cancer...
Romagnuolo M, Alberti Violetti S, Riva D, et al.Vitiligo-like
lesions inducedby cyclin-dependent kinase 4/6 inhibitor
palbociclib Int J Dermatol....
Abd Elmageed ZY, Gaur RL, Williams M, et al. Raj M.H.,et al.
Characterization of coordinated immediate responses by
p16INK4A and p53 pathways...
Zarkavelis G, Kollas A, Kampletsas E, et al. Aromatase
inhibitors induced autoimmune disorders in patients with
breast cancer: a review. J...
